Multi-Kernel Classification for Integration of Clinical and Imaging Data: Application to Prediction of Cognitive Decline in Older Adults
Diagnosis of neurologic and neuropsychiatric disorders typically involves considerable assessment including clinical observation, neuroimaging, and biological and neuropsychological measurements. While it is reasonable to expect that the integration of neuroimaging data and complementary non-imaging measures is likely to improve early diagnosis on individual basis, due to technical challenges associated with the task of combining different data types, medical image pattern recognition analysis has been largely focusing solely on neuroimaging evaluations. In this paper, we explore the potential of integrating neuroimaging and clinical information within a pattern classification framework, and propose that the multi-kernel learning (MKL) paradigm may be suitable for building a multimodal classifier of a disorder, as well as for automatic identification of the relevance of each information type. We apply our approach to the problem of detecting cognitive decline in healthy older adults from single-visit evaluations, and show that the performance of a classifier can be improved when nouroimaging and clinical evaluations are used simultaneously within a MKL-based classification framework.
KeywordsMulti-Kernel Learning (MKL) Normal aging MRI
Unable to display preview. Download preview PDF.
- 1.Benton, A.: Revised Visual Retention Test. The Psych. Corp., New York (1974)Google Scholar
- 4.Davatzikos, C., Bhatt, P., Shaw, L.M., Batmanghelich, K.N., Trojanowski, J.Q.: Prediction of mci to ad conversion, via mri, csf biomarkers, and pattern classification. Neurobiology of Aging (2010) (in press, corrected proof )Google Scholar
- 5.Delis, D., Kramer, J., Kaplan, E., Ober, B.: California Verbal Learning Test - Research Edition. The Psychological Corporation, New York (1987)Google Scholar
- 10.Ji, Y., Permanne, B., Sigurdsson, E.M., Holtzman, D.M., Wisniewski, T.: Amyloid beta40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoe knock-out and human apoe3 or e4 expressing transgenic mice. J. Alzheimers Dis. 3(1), 23–30 (2001)CrossRefGoogle Scholar
- 12.de Leon, M., Mosconi, L., Li, J., De Santi, S., Yao, Y., Tsui, W., Pirraglia, E., Rich, K., Javier, E., Brys, M., Glodzik, L., Switalski, R., Saint Louis, L., Pratico, D.: Longitudinal csf isoprostane and mri atrophy in the progression to ad. Journal of Neurology 254, 1666–1675 (2007)CrossRefGoogle Scholar
- 15.Resnick, S.M., Pham, D.L., Kraut, M.A., Zonderman, A.B., Davatzikos, C.: Longitudinal magnetic resonance imaging studies of older adults: A shrinking brain. J. Neurosci. 23(8), 3295–3301 (2003)Google Scholar